MedTrace Logo

Effects of High-Dose Resveratrol in Non-Diabetic Obese Males

NCT02247596 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2014-09-25

No results posted yet for this study

Summary

The primary aim of our study was to examine the effects of two weeks of oral resveratrol on resting energy expenditure and insulin sensitivity in non-diabetic obese male subjects. Secondary variables included plasma lipid subfraction, blood pressure and glycated hemoglobin (HbA1c).

Conditions

Interventions

DRUG

Resveratrol

1g tds 2 weeks

DRUG

Placebo

Sugar pill 1g tds for 2 weeks

Sponsors & Collaborators

  • National Medical Research Council (NMRC), Singapore

    collaborator OTHER_GOV

  • Khoo Teck Puat Hospital

    lead OTHER

Principal Investigators

  • Kian Peng Goh · Khoo Teck Puat Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02247596 on ClinicalTrials.gov